Tissue Regenix Group Plc Working Capital to Net Assets Ratio
Tissue Regenix Group Plc working capital to net assets ratio. Tissue Regenix Group Plc (TRX) has a Working Capital to Net Assets ratio of 52.0% as of June 2025. Working capital of GBX14.88 Million (current assets of GBX22.79 Million minus current liabilities of GBX7.91 Million) is measured against net assets of GBX28.62 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Tissue Regenix Group Plc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Tissue Regenix Group Plc (2008–2024)
Working capital to net assets ratio of Tissue Regenix Group Plc from 2008 to 2024. This chart shows how Tissue Regenix Group Plc's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2008 to 2024. As of June 2025, the ratio stands at 52.0%, reflecting working capital of GBX14.88 Million against net assets of GBX28.62 Million GBX. See Tissue Regenix Group Plc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Tissue Regenix Group Plc Working Capital to Net Assets Ratio by Year (2008–2024)
Tissue Regenix Group Plc working capital to net assets ratio by year from 2008 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Tissue Regenix Group Plc from 2008 to 2024, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see TRX total asset value.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 52.0% | GBX15.12 Million | GBX29.06 Million | GBX21.27 Million | GBX6.16 Million | ▲ +3.1 pp |
| 2023 | 48.9% | GBX14.36 Million | GBX29.36 Million | GBX19.09 Million | GBX4.74 Million | ▲ +2.7 pp |
| 2022 | 46.2% | GBX11.67 Million | GBX25.27 Million | GBX18.32 Million | GBX6.64 Million | ▼ -6.8 pp |
| 2021 | 53.0% | GBX13.07 Million | GBX24.65 Million | GBX16.29 Million | GBX3.22 Million | ▼ -7.4 pp |
| 2020 | 60.4% | GBX16.83 Million | GBX27.85 Million | GBX20.09 Million | GBX3.26 Million | ▲ +31.9 pp |
| 2019 | 28.6% | GBX7.02 Million | GBX24.59 Million | GBX10.14 Million | GBX3.12 Million | ▼ -4.0 pp |
| 2018 | 32.5% | GBX10.60 Million | GBX32.57 Million | GBX14.90 Million | GBX4.30 Million | ▼ -14.7 pp |
| 2018 | 47.3% | GBX18.68 Million | GBX39.52 Million | GBX23.46 Million | GBX4.78 Million | ▲ +0.0 pp |
| 2017 | 47.3% | GBX18.68 Million | GBX39.52 Million | GBX23.46 Million | GBX4.78 Million | ▼ -38.5 pp |
| 2016 | 85.8% | GBX9.90 Million | GBX11.54 Million | GBX11.96 Million | GBX2.06 Million | ▼ -9.9 pp |
| 2016 | 95.8% | GBX28.97 Million | GBX30.25 Million | GBX31.75 Million | GBX2.79 Million | ▼ -0.5 pp |
| 2015 | 96.2% | GBX11.14 Million | GBX11.58 Million | GBX12.24 Million | GBX1.09 Million | ▼ -1.3 pp |
| 2014 | 97.5% | GBX30.53 Million | GBX31.30 Million | GBX32.35 Million | GBX1.82 Million | ▼ -1.5 pp |
| 2013 | 99.0% | GBX38.27 Million | GBX38.64 Million | GBX39.35 Million | GBX1.08 Million | ▼ -0.4 pp |
| 2012 | 99.4% | GBX43.53 Million | GBX43.78 Million | GBX44.55 Million | GBX1.02 Million | ▲ +2.5 pp |
| 2011 | 97.0% | GBX9.54 Million | GBX9.84 Million | GBX9.94 Million | GBX400.37K | ▼ -3.0 pp |
| 2010 | 100.0% | GBX3.67 Million | GBX3.67 Million | GBX3.72 Million | GBX51.12K | ▲ +0.1 pp |
| 2009 | 99.9% | GBX3.63 Million | GBX3.63 Million | GBX3.69 Million | GBX60.53K | ▲ +43.5 pp |
| 2008 | 56.4% | GBX5.46 Million | GBX9.68 Million | GBX5.55 Million | GBX83.52K | — |